{
  "@context": {
    "dcterms": "http://purl.org/dc/terms/",
    "cito": "http://purl.org/spar/cito/",
    "deo": "http://purl.org/spar/deo/"
  },
  "@id": "https://hypothesis.bioagent.ai/ipk613v6jp",
  "@type": "deo:FutureWork",
  "cito:usesDataFrom": [
    "https://doi.org/10.1186/s13041-024-01028-8",
    "https://doi.org/10.1002/dad2.12391",
    "https://doi.org/10.1234/example"
  ],
  "dcterms:references": [
    "# Mechanistic Hypothesis Connecting DOPAL's Anti-Oligomerization Effects with Neprilysin-Mediated Aβ Clearance\n\n## 1. Background\nDOPAL (3,4-dihydroxyphenylacetaldehyde) is a reactive metabolite produced during dopamine oxidation by monoamine oxidase that has been shown to decrease Aβ oligomerization in human neuroblastoma cells, thereby reducing Aβ cytotoxicity. Neprilysin (NEP) is an established Aβ-degrading enzyme that primarily targets monomeric Aβ forms for proteolytic degradation. As evidenced in the provided abstract, L-DOPA administration significantly decreases Aβ plaque number in 5xFAD mice specifically by upregulating neprilysin and ADAM17 levels, suggesting a potential connection between dopaminergic pathways and Aβ clearance mechanisms.\n\n## 2. Knowledge Gap\nWhile both DOPAL and neprilysin influence Aβ processing, their potential functional interaction remains unexplored. It is unknown whether DOPAL-induced conformational changes in Aβ peptides might influence neprilysin's substrate recognition and degradation efficiency, potentially creating a coordinated system where dopamine metabolism affects both Aβ oligomerization state and degradation susceptibility.\n\n## 3. Central Hypothesis\nDOPAL promotes a structural conformation of Aβ that simultaneously prevents oligomerization and enhances recognition by neprilysin, establishing a dopamine metabolism-dependent neuroprotective pathway against Aβ accumulation.\n\n## 4. Proposed Mechanism\n1. DOPAL, generated through dopamine metabolism via monoamine oxidase, binds to specific hydrophobic regions of Aβ peptides that typically mediate β-sheet formation during oligomerization.\n2. This binding induces structural changes in Aβ that maintain it in a monomeric, extended conformation rather than allowing it to adopt β-sheet-rich conformations required for oligomerization.\n3. The DOPAL-induced extended conformation of Aβ enhances the exposure and accessibility of critical neprilysin cleavage sites that would otherwise be buried or sterically hindered in oligomeric forms.\n4. Concurrently, dopaminergic signaling (enhanced by L-DOPA) upregulates neprilysin expression through downstream transcriptional pathways, creating a synchronized system of increased substrate availability and elevated enzyme levels.\n5. This coordinated process ensures efficient degradation of Aβ monomers before they can aggregate into toxic oligomers, effectively reducing both Aβ toxicity and plaque formation.\n\n## 5. Testable Predictions\n1. Pretreatment of synthetic Aβ with physiologically relevant concentrations of DOPAL should significantly enhance the rate and efficiency of subsequent neprilysin-mediated degradation compared to untreated Aβ.\n2. Inhibition of MAO activity (reducing DOPAL production) in neuronal cultures or AD mouse models should decrease the efficiency of neprilysin-mediated Aβ clearance despite unchanged neprilysin expression levels.\n3. Mass spectrometry and structural analysis of DOPAL-bound Aβ should reveal specific conformational changes that correlate with increased exposure of known neprilysin cleavage sites compared to unmodified Aβ.\n\n## 6. Potential Experimental Approaches\n1. Develop a sequential in vitro assay system where synthetic Aβ is first incubated with varying concentrations of DOPAL, followed by addition of recombinant neprilysin. Use HPLC and mass spectrometry to quantify both the degradation rate and specific cleavage products, while circular dichroism and NMR could characterize conformational changes induced by DOPAL binding.\n\n2. Create a neuronal cell model expressing fluorescently labeled Aβ to visualize in real-time how modulation of DOPAL levels (via MAO inhibitors or overexpression) affects both Aβ aggregation state and clearance. This could be complemented with CRISPR-mediated knockdown of neprilysin to confirm the specific role of this enzyme in the proposed pathway.\n\nThis hypothesis provides a novel mechanistic link between two previously unconnected observations about Aβ processing, suggesting that dopamine metabolism may have evolved a coordinated system to both prevent Aβ oligomerization through DOPAL production and enhance its clearance through neprilysin upregulation. This model could help explain why disruptions in dopaminergic systems often precede or accompany Aβ accumulation in neurodegenerative disorders."
  ],
  "dcterms:subject": [
    "amyloid beta",
    "Metabolism"
  ],
  "dcterms:source": [
    "DOPAL, a dopamine metabolite, decreases Aβ oligomerization in human neuroblastoma cells, reducing the cytotoxic effects of Aβ.",
    "The study shows that neprilysin acts as an Aβ-degrading enzyme, particularly affecting monomeric Aβ"
  ],
  "dcterms:abstract": [
    "Dopamine plays important roles in cognitive function and inflammation and therefore is involved in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD). Drugs that increase or maintain dopamine levels in the brain could be a therapeutic strategy for AD. However, the effects of dopamine and its precursor levodopa (L‑DOPA) on Aβ/tau pathology in vivo and the underlying molecular mechanisms have not been studied in detail. Here, we investigated whether L‑DOPA treatment alters neuroinflammation, Aβ pathology, and tau phosphorylation in 5xFAD mice, a model of AD. We found that L‑DOPA administration significantly reduced microgliosis and astrogliosis in 5xFAD mice. In addition, L‑DOPA treatment significantly decreased Aβ plaque number by upregulating NEP and ADAM17 levels in 5xFAD mice. However, L‑DOPA‑treated 5xFAD mice did not exhibit changes in tau hyperphos‑phorylation or tau kinase levels. These data suggest that L‑DOPA alleviates neuroinflammatory responses and Aβ pathology but not tau pathology in this mouse model of AD.",
    "[18F]AZD4694 is an amyloid beta (Aβ) imaging agent used in several observational studies and clinical trials. This study assessed 146 individuals evaluated with [18F]AZD4694 at baseline and a 2‐year follow‐up, revealing longitudinal patterns of Aβ accumulation. Results showed that cognitively unimpaired older adults displayed subtle Aβ accumulation, while Aβ positive cases exhibited greater increases, underscoring the agent’s potential to monitor Aβ levels in clinical settings.",
    "Background: Pseudoexfoliation syndrome (PEX) is a common age-related ocular condition characterized by the accumulation of a fibrillar, pseudoexfoliative material on the anterior segment of the eye. This study aims to investigate the histopathological characteristics of pseudoexfoliative material within different ocular structures. Methods: A total of 32 anterior lens capsules, 3 eyelid fragments, and 12 conjunctival specimens were obtained from patients clinically diagnosed with PEX during ocular surgeries. Results: PEX material, characterized by its fibrillar components, is consistently present across multiple ocular structures. The presence of fibrillar eosinophilic deposits across these structures highlights the systemic distribution of PEX material. Conclusions: The involvement of the eyelid and conjunctiva plays a crucial role in understanding PEX pathophysiology.",
    "Movement disorders (MD) have been linked to degeneration of the substantia nigra (SN) in Parkinson’s disease and include bradykinesia, rigidity, and tremor. They are also present in frontotemporal dementia (FTD), where MD have been linked to frontotemporal lobar degeneration with tau pathology (FTLD-tau). The aims of this study are to characterize the frequency and the nature of MD in a cohort of FTLD-TDP brain donors and to investigate the relationship between the presence of MD, the nigral neuronal loss, and the TDP-43 burden in the SN.",
    "This study investigates the relationship between degeneration/regeneration and tubular aggregates (TA) in aged murine models, revealing that TA formation occurs during muscle degeneration but does not correlate with functional improvement.",
    "Heteroplasmy occurs when wild-type and mutant mitochondrial DNA (mtDNA) molecules coexist in single cells. We investigate the dynamics of heteroplasmy in dividing cells and demonstrate that selection acts at the level of cell fitness, influencing the maintenance and purging of nonsynonymous and synonymous mtDNA variants depending on environmental conditions.",
    "Fibrogenesis is part of a normal protective response to tissue injury that can become irreversible and progressive, leading to fatal diseases. Senescent cells are a main driver of fibrotic diseases through their secretome, known as the senescence-associated secretory phenotype (SASP). Here, we report that cellular senescence, and multiple types of fibrotic diseases in mice and humans are characterized by the accumulation of iron...",
    "Age-related decline in mobility and cognition are associated with cellular senescence and NAD + depletion in dogs and people. A combination of a novel NAD + precursor and senolytic, LY-D6/2, was examined in this randomized controlled trial. Seventy dogs with mild to moderate cognitive impairment were enrolled and allocated into placebo, low or full dose groups. Primary outcomes were change in cognitive impairment measured with the owner-reported Canine Cognitive Dysfunction Rating (CCDR) scale and change in activity measured with physical activity monitors.",
    "Alzheimer's disease is a neurodegenerative disorder characterized pathologically by amyloid-beta plaques, tau tangles, and neuronal loss. Our study investigates the role of CSF 14-3-3β in cognitive decline in Alzheimer's disease by analyzing data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). We found that higher CSF 14-3-3β levels correlate with cognitive impairment and other Alzheimer's disease biomarkers, indicating its potential as a diagnostic tool."
  ]
}